Company: RGNT
Filing Date: 2025-02-12
Form Type: DRS/A
Source: 0001213900-25-012299
Chunk: 149

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-02-12
Form: DRS/A
Chunk 149
---

Institute, Philadelphia. Since 1995, he has been the General Partner of Medica Venture Partners. Mr. Geller was selected to serve
on the board of directors as Chairman due to his significant experience leading and growing companies in the pharmaceutical industry and
his significant leadership experience. His experience leading the Company’s management and the depth of his knowledge of our business
enable him to provide valuable leadership on complex business matters that we face on an ongoing basis. Dr. Geller will devote approximately
50% of his time to the Company, as an executive Chairman, upon completion of this offering as he also is currently employed by Medica
Venture Partners.

Dr. Eli Hazum, Chief Executive Officer

Dr. Eli Hazum has served
as our Chief Executive Officer since October 2021. He has been a partner and Chief Security Officer of Medica Venture Partners since
1995. Prior to joining Medica, Prof. Hazum spent five years at Glaxo Inc. as Head of the Department of Receptor Research and
Metabolic Diseases and as a member of the Corporate Committee for New Technology Identification in osteoporosis, worldwide. Mr.
Hazum received his Ph.D. degree in the field of hormone biochemistry from the Weizmann Institute of Science, B.Sc and M.Sc degrees
in Chemistry from Tel Aviv University and an executive MBA degree from Humberside University in the UK.

<div align='center'>90</div>

Mr. Arie Gordashnikov, CPA, Chief Financial Officer

Mr. Arie Gordashnikov has
been our Chief Financial Officer since October 2022. He has served as Head of Initial Public Offering, or IPO, and Mergers and Acquisitions
Department at Shimony Yosef Certified Public Accountant (Isr.), or Shimony, since 2018. Mr. Gordashnikov has over 13 years’ experience
in accounting, auditing and finance of Hi-Tech and biotechnology companies. Before joining Shimony, Mr. Gordashnikov was an audit manager
at Ernst & Young Israel. Mr. Gordashnikov holds an MBA degree from Tel Aviv University in financial management, a B.A. in Accounting
and Economics from Hebrew University of Jerusalem, and has been a licensed CPA since 2012.

Mr. Jeff Dykan, CPA, Director

Mr. Jeff Dykan has served
on our Board of Directors since 2005. He was appointed by our shareholder SCP Vitalife. Since